Better Health for All

Labcorp's core business, encompassing over 5,000 diagnostic tests

and processing 2.7 billion tests in 2022, delivers substantial health benefits by enhancing public health, patient care, and outcomes. The company's partnerships and acquisitions integrate diagnostic tools into healthcare networks, aiming for efficient patient care and clinical innovation. There is no evidence indicating that Labcorp generates revenue from products or activities with negative health outcomes. The company's operations do not involve products with addiction potential, nor does it produce or sell food or nutritional products. While Labcorp provides drug development services, there is no evidence that it holds healthcare-related patents or intellectual property on pharmaceutical products.

Fair Money & Economic Opportunity

Laboratory Corporation of America Holdings (Labcorp) operates primarily in the healthcare sector, providing diagnostic and research services.

Its core business does not involve offering consumer lending, deposit, or other financial products. Consequently, all KPIs related to financial services such as underserved client share, pricing fairness, exploitative fee exposure, inclusion initiatives, data accessibility, fair lending compliance, wealth building outcome, profit reinvestment, financial literacy initiatives, debt burden ratio, geographic inclusion, and product simplicity are not applicable to its operations and are scored 0. While Labcorp engaged with over 500 diverse suppliers in 2021, this procurement activity does not directly align with the specific financial product-focused metrics of the inclusion initiatives or profit reinvestment KPIs. Legal actions concerning wage and hour violations or Medicaid billing practices fall outside the scope of this value, which focuses on fair financial services for consumers.

Fair Pay & Worker Respect

In 2023, a LabCorp subsidiary, LabCorp Central Laboratory Services Inc., settled a hiring discrimination case for $525,000.

This involved discrimination against Black and Asian applicants at its Indianapolis facility, leading to job offers for affected applicants and revised hiring policies.

Fair Trade & Ethical Sourcing

Labcorp has established a Supplier Oversight and Business Diversity Program that engages with over 500 diverse suppliers, including those owned by minorities, women, veterans, disabled individuals, and economically disadvantaged groups.

The company is committed to combatting modern slavery and human trafficking, having implemented policies and published statements to ensure its supply chain is free from exploitation. Furthermore, Labcorp has a Supplier Code of Conduct that prohibits forced labor, child labor, and exploitation, emphasizing fair wages, safe working conditions, and human rights, which suppliers must adhere to. However, the provided articles do not contain specific quantitative data points required by the rubric, such as the percentage of spend on fair-trade certified inputs, audit frequency, number of substantiated labor incidents, supply chain traceability coverage, remediation speed, the percentage of contracts with ethical clauses, the share of spend on high-risk materials, or the percentage of procurement budget directed to diverse suppliers.

Honest & Fair Business

Labcorp incurred $21.625 million in ethics-related settlements and payments within the past three years. This includes a $19 million settlement in February 2023 for False Claims Act allegations related to kickbacks

, a $2.1 million payment in March 2023 to resolve a whistleblower lawsuit concerning unreturned overpayments for genetic tests , and a $525,000 payment in January 2023 by a subsidiary to settle employment discrimination claims .

Kind to Animals

Labcorp has faced USDA citations for animal welfare violations from 2011-2014, including incidents where monkeys suffered frostbite, hyperthermia, and inadequate care

. A Texas research facility was also fined in 2016 for the deaths of primates . Despite these issues, Labcorp has publicly committed to the humane treatment of animals, emphasizing care and ethical standards , and launched a global 'Culture of CARE' program to enhance animal welfare . These past violations suggest inconsistent enforcement of its animal testing policy. In 2023, Labcorp's board recommended against shareholder proposals from PETA requesting annual reports on primate transport and disclosure of animal welfare practices, stating current disclosures were sufficient . This indicates a reactive engagement with welfare policies and an advocacy for minimal standards.

No War, No Weapons

Laboratory Corporation of America Holdings (Labcorp) primarily operates in the healthcare sector, focusing on diagnostic and laboratory services.

Its core business is explicitly unrelated to arms manufacturing, military operations, or weapon production. The company's services do not involve technologies with both civilian and military applications. Labcorp has secured contracts with the U.S. Department of Defense and the Department of Veterans Affairs for clinical reference laboratory testing services, including approximately $17.2 million during the COVID-19 pandemic, a $46.4 million contract in 2018, and a $971.95 million contract with the VA in 2015. These contracts are for healthcare provision and do not engage in armament production or facilitate conflict. In March 2023, Labcorp agreed to pay $2.1 million to settle allegations of overbilling the DoD for genetic tests, which pertained to billing practices and not military operations or weapons.

Planet-Friendly Business

Labcorp reported total Scope 1, 2, and 3 greenhouse gas emissions of 1.34 million tCO2e in 2024, representing a 3.29% decrease from 2023.

The company's science-based targets, approved by SBTi in 2023, are aligned with a 1.5°C pathway, aiming to reduce absolute Scope 1 and 2 GHG emissions by 42% and Scope 3 emissions by 25% by 2030 from a 2020 baseline. In 2024, 23% of its total electricity purchased was from renewable sources. The company achieved an 83% overall waste diversion rate in 2024. Additionally, 9% of Labcorp's total water withdrawal is sourced from sites within high water stress areas. The company reports metrics through the TCFD framework, and its materiality assessment adheres to TCFD.

Respect for Cultures & Communities

The provided articles describe Labcorp's commitment to diversity, equity, and inclusion through expanded training, mentoring programs, and Employee Resource Groups (ERGs) with 106 chapters in 15 countries as of 2022.

The company's Charitable Foundation invested in over 70 programs in 2021 focusing on health, education, and community support globally. However, the articles do not provide specific, quantifiable evidence directly addressing any of the defined KPIs for 'Respect for Cultures & Communities,' such as formal partnerships with indigenous groups, percentage of revenue reinvested in local community development, cultural appropriation incidents, or cultural sensitivity training completion rates.

Safe & Smart Tech

Labcorp faces multiple class-action lawsuits from 2023

and 2024 alleging unauthorized sharing of patients' personal health information and online activity data with third parties like Meta and Google, without consent . A U.S. District Judge denied Labcorp's motion to dismiss these claims . In July 2023, Labcorp also mistakenly sent faxes with lab test results and personal information to incorrect numbers due to a technical error , offering affected individuals identity protection services . The company implements a comprehensive information security program that includes multi-factor authentication , industry-standard 256-bit encryption , regular penetration testing , and vulnerability scans .

Zero Waste & Sustainable Products

Labcorp has implemented 11 distinct waste reduction initiatives.

These include switching to paper bags at over 300 patient specimen collection sites, reducing plastic bag use by more than 180,000 bags annually. The company digitized its Custody and Control Form, saving over 26,000 pages of paper per year, and consolidated blood tests, saving 1 million tubes and labels and more than 2,000 liters of blood. Other initiatives involve ordering in bulk, educating lab staff on waste separation, implementing green meeting guidelines, using reusable kitchen supplies, conducting waste walks, launching a Dynacare waste reduction program, placing battery recycling collection boxes, and donating surplus computer equipment since 2007. Labcorp has set quantitative waste reduction targets with timelines, aiming to increase its waste reclaim rate by 10% and reduce regulated medical waste generated by 5% by 2025, both using a 2020 baseline. However, the company has a history of waste disposal issues, including one air pollution violation in 2025. Furthermore, multiple hazardous waste violations have been recorded for Labcorp entities between 2004 and 2019.